StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) stock

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3027% above fair value
$420.95−9.58 (-2.23%)

Close on Nov 18, 2026Market cap $145.92BP/E 50.9Yield –

Intuitive Surgical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Intuitive Surgical's revenue for the twelve months ending Sep 30, 2026 was $11.58B, up 20.5% year over year. For fiscal 2025 it was $10.06B, up 20.5% from the year before. Over ten years it grew 15.5% a year on average. The highest annual figure on record is $10.06B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.06B+20.5%
FY2024Dec 31, 2024$8.35B+17.2%
FY2023Dec 31, 2023$7.12B+14.5%
FY2022Dec 31, 2022$6.22B+9.0%
FY2021Dec 31, 2021$5.71B+31.0%
FY2020Dec 31, 2020$4.36B-2.7%
FY2019Dec 31, 2019$4.48B+20.3%
FY2018Dec 31, 2018$3.72B+18.7%
FY2017Dec 31, 2017$3.14B+16.0%
FY2016Dec 31, 2016$2.71B+13.5%
FY2015Dec 31, 2015$2.38B+11.9%
FY2014Dec 31, 2014$2.13B-5.9%
FY2013Dec 31, 2013$2.27B+4.0%
FY2012Dec 31, 2012$2.18B+24.0%
FY2011Dec 31, 2011$1.76B+24.4%
FY2010Dec 31, 2010$1.41B+34.3%
FY2009Dec 31, 2009$1.05B+20.3%
FY2008Dec 31, 2008$874.90M+45.6%
FY2007Dec 31, 2007$600.83M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.05B+21.7%
Q2 FY2026Jun 30, 2026$2.89B+18.5%
Q1 FY2026Mar 31, 2026$2.77B+23.0%
Q4 FY2025Dec 31, 2025$2.87B+18.8%
Q3 FY2025Sep 30, 2025$2.51B+22.9%
Q2 FY2025Jun 30, 2025$2.44B+21.4%
Q1 FY2025Mar 31, 2025$2.25B+19.2%
Q4 FY2024Dec 31, 2024$2.41B+25.2%
Q3 FY2024Sep 30, 2024$2.04B+16.9%
Q2 FY2024Jun 30, 2024$2.01B+14.5%
Q1 FY2024Mar 31, 2024$1.89B+11.5%
Q4 FY2023Dec 31, 2023$1.93B+16.5%
Q3 FY2023Sep 30, 2023$1.74B+12.0%
Q2 FY2023Jun 30, 2023$1.76B+15.4%
Q1 FY2023Mar 31, 2023$1.70B+14.0%
Q4 FY2022Dec 31, 2022$1.66B+6.7%
Q3 FY2022Sep 30, 2022$1.56B+11.0%
Q2 FY2022Jun 30, 2022$1.52B+4.0%
Q1 FY2022Mar 31, 2022$1.49B+15.1%
Q4 FY2021Dec 31, 2021$1.55B+16.7%
Q3 FY2021Sep 30, 2021$1.40B+30.2%
Q2 FY2021Jun 30, 2021$1.46B+71.8%
Q1 FY2021Mar 31, 2021$1.29B+17.5%
Q4 FY2020Dec 31, 2020$1.33B+4.0%
Q3 FY2020Sep 30, 2020$1.08B-4.5%
Q2 FY2020Jun 30, 2020$852.10M-22.5%
Q1 FY2020Mar 31, 2020$1.10B+12.9%
Q4 FY2019Dec 31, 2019$1.28B+22.1%
Q3 FY2019Sep 30, 2019$1.13B+22.5%
Q2 FY2019Jun 30, 2019$1.10B+20.9%
Q1 FY2019Mar 31, 2019$973.70M+14.9%
Q4 FY2018Dec 31, 2018$1.05B+17.3%
Q3 FY2018Sep 30, 2018$920.90M+14.0%
Q2 FY2018Jun 30, 2018$909.30M+19.8%
Q1 FY2018Mar 31, 2018$847.50M+24.7%
Q4 FY2017Dec 31, 2017$892.00M+17.8%
Q3 FY2017Sep 30, 2017$807.80M–
Q2 FY2017Jun 30, 2017$758.80M–
Q1 FY2017Mar 31, 2017$679.60M–
Q4 FY2016Dec 31, 2016$756.90M–

More Intuitive Surgical figures

See a number that looks wrong?